Westlake Chemical Partners LP
Westlake Chemical Partners LP (WLKP) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Westlake Chemical Partners LP (WLKP), featuring income statements, balance sheets, and cash flow data.
Westlake Chemical Partners LP (WLKP) Income Statement & Financial Overview
View the income breakdown for Westlake Chemical Partners LP WLKP across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $297.12M | $237.63M | $290.06M | $277.00M |
| Cost of Revenue | $199.59M | $183.55M | $191.48M | $160.05M |
| Gross Profit | $97.53M | $54.08M | $98.58M | $116.94M |
| Gross Profit Ratio | $0.33 | $0.23 | $0.34 | $0.42 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.30M | $7.47M | $6.56M | $7.25M |
| Operating Expenses | $6.30M | $7.47M | $6.56M | $7.25M |
| Total Costs & Expenses | $205.89M | $191.02M | $198.03M | $167.31M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$5.91M | -$5.54M | $5.77M | $6.70M |
| Depreciation & Amortization | $0.00 | $9.73M | $27.48M | $28.11M |
| EBITDA | $91.23M | $46.61M | $140.27M | $139.13M |
| EBITDA Ratio | $0.31 | $0.20 | $0.48 | $0.50 |
| Operating Income | $91.23M | $46.61M | $92.03M | $109.69M |
| Operating Income Ratio | $0.31 | $0.20 | $0.32 | $0.40 |
| Other Income/Expenses (Net) | -$5.23M | -$4.19M | -$4.44M | -$5.37M |
| Income Before Tax | $86.00M | $42.42M | $87.59M | $104.32M |
| Income Before Tax Ratio | $0.29 | $0.18 | $0.30 | $0.38 |
| Income Tax Expense | $205000.00 | $107000.00 | $202000.00 | $216000.00 |
| Net Income | $85.80M | $42.31M | $15.00M | $18.14M |
| Net Income Ratio | $0.29 | $0.18 | $0.05 | $0.07 |
| EPS | $0.00 | $1.20 | $0.43 | $0.51 |
| Diluted EPS | $0.00 | $1.20 | $0.43 | $0.51 |
| Weighted Avg Shares Outstanding | $0.00 | $35.23M | $35.24M | $35.23M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $35.23M | $35.24M | $35.23M |
The company's financials show resilient growth, with revenue advancing from $277.00M in Q3 2024 to $297.12M in Q2 2025. Gross profit remained healthy with margins at 33% in Q2 2025 compared to 42% in Q3 2024. Operating income hit $91.23M last quarter, sustaining a consistent 31% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $91.23M. Net income rose to $85.80M, while earnings per share reached $0.00. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan